| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |